Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Atacicept: targeting B cells in multiple sclerosis - PMC
Frontiers | Systematic Review of Safety and Efficacy of Atacicept in ...
Atacicept • Vera Therapeutics
Frontiers | Telitacicept for autoimmune nephropathy
PPT - USING BIOMARKERS FOR EARLY PHASE DOSE SELECTION WITH PROTEIN ...
Full article: Site-specific N- and O-glycosylation analysis of atacicept
| Hypothetical model for the binding of belimumab and atacicept to ...
10亿美元分子：Vera大涨49%，Atacicept治疗IgA肾病2b期临床成功 Armstrong 2023年1月25日， Vera ...
Binding of atacicept to BAFF 60-mer does not induce BAFF dissociation ...
(PDF) Atacicept: Targeting B cells in multiple sclerosis
Science • Vera Therapeutics
Atacicept Top # 12 Facts - YouTube
Biological therapeutic agents ppt | PPTX
Frontiers | Kinetics of free and ligand-bound atacicept in human serum
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo ...
Multimers of atacicept bind to proteoglycans. (a) Size exclusion ...
Atacicept prevents B cell repopulation but not isotype switching or ...
Atacicept: Uses, Dosage, Side Effects, Food Interaction & FAQ
Atacicept does not interfere with heparin activity. (a) Heparin ...
A phase 2b, randomized, double-blind, placebo-controlled, clinical ...
Significant antimyeloma efficacy of atacicept, but not BAFFR-Ig, in ...
Atacicept (TACI-Ig) | B Cell Stimulator | MedChemExpress
阿塞西普(Atacicept) - 药物靶点：APRIL x BAFF_在研适应症：免疫球蛋白a肾病，肾小球疾病，先天性肾病_专利_临床_研发
Atacicept – Application in Therapy and Current Clinical Research
Atacicept treatment reduced antibody-mediated injuries | Download ...
Inside the ORIGIN study: Visual and video abstracts on atacicept for ...
Atacicept: Uses, Interactions, Mechanism of Action | DrugBank Online
Safety and Efficacy of Atacicept in Combination With Rituximab for ...
(PDF) Telitacicept, a novel humanized, recombinant TACI-Fc fusion ...
A) The change in median free atacicept concentration during disease ...
Povetacicept, an Enhanced Dual APRIL/BAFF Antagonist That Modulates B ...
Free atacicept serum concentration versus time profiles after ...
Efficacy and safety of atacicept for prevention of flares in patients ...
Atacicept（阿塞西普）深度分析：专利、文献与序列数据的全面解读 - 知乎
Atacicept Phase 3 Data Highlights Vera Therapeutics' Path to Potential ...
(PDF) Phase I Clinical Study of Atacicept in Patients with Relapsed and ...
FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A ...
Antimyeloma response of atacicept in myeloma-osteoclast cocultures. (a ...
atacicept | PDF | Medical Specialties | Clinical Medicine
Atacicept in IgAN - Vera Therapeutics
Phase 3 ORIGIN Sets Stage for Atacicept in IgA Nephropathy, with ...
WCN25-2470 Long-term Results from the ORIGIN Phase 2b Study of ...
Relative quantitation of N-glycoforms of atacicept. (a) Released ...
Atacicept in combination with MMF and corticosteroids in lupus ...
Atacicept for IgA Nephropathy: Long-Term Results from the ORIGIN Phase ...
IgA肾病药物Atacicept获FDA授予突破性疗法称号-上市-医保-临床适应症-香港济民药业
Attainment of treat-to-target endpoints in SLE patients with high ...
User | poteaudailynews.com - Vera Therapeutics Announces Positive Week ...
Atacicept in IgA Nephropathy: Analysis of the Interim Phase 3 Data in ...
New Hope for Kidney Disease: Vera Therapeutics’ Atacicept Advances ...
Efficacy and Safety of Atacicept in Patients With Systemic Lupus ...
Figure 1 from Integrated safety profile of atacicept: an analysis of ...
Vera Therapeutics Announces Expanded Atacicept Development
(PDF) Atacicept in multiple sclerosis (ATAMS): a randomised, placebo ...
ORIGIN 3 Clinical Trial Evaluating Atacicept in Adults With IgA ...
Atacicept in patients with rheumatoid arthritis: Results of a ...
Population pharmacokinetics of atacicept in systemic lupus ...
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase ...
Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC
Phase 2b and Phase 3 ORIGIN Trials of Atacicept in IgAN | HCPLive
Vera Therapeutics Announces Positive Topline Results of Phase 2b ORIGIN ...
No interactions between heparin and atacicept, an antagonist of B cell ...
WCN24-1414 ORIGIN 3: PIVOTAL PHASE 3 STUDY EVALUATING EFFECT OF ...
Atacicept (TACI-Ig) inhibits growth of TACIhigh primary myeloma cells ...
Vera Therapeutics Releases 36 Week Interim Analysis of Phase 2b ...
(PDF) 210 Integrated safety profile of atacicept from all clinical ...
Atacicept reduces proteinuria for adults with IgA nephropathy
Neutralizing BAFF/APRIL With Atacicept Prevents Early DSA Formation and ...
Therapeutic Advances in IgA Nephropathy: Atacicept and B-Cell ...
智慧芽Bio数据库：助力Atacicept（阿塞西普）生物序列研究与专利分析 - 知乎
Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association ...
Randomized Phase II JANUS Study of Atacicept in Patients With IgA ...
WCN24-1294 ATACICEPT REDUCES HEMATURIA AND SERUM GD-IGA1, BOTH ...
Atacicept in patients with rheumatoid arthritis and an inadequate ...
Atacicept reduced the level of early de novo DSA | Download Scientific ...
Vera Therapeutics Submits Biologics License Application to U.S. FDA ...
Atacicept for IgA nephropathy succeeds in phase III trial ...
Profile of Atacicept and Its Potential in the Treatment of Systemic ...
Full article: The Latest Progress in the Application of Telitacicept in ...
